An attorney for plaintiffs in massive generic drug price-fixing litigation urged a judge to demand corrections from firms that are allegedly trying to lure plaintiffs into contracts to recover money from settlements in exchange for a share of the payments.
The motion on behalf of the end-payer plaintiffs filed Tuesday in the US District Court for the Eastern District of Pennsylvania accuses a slew of claims recovery firms of false and misleading communication to class members.
Roberta D. Liebenberg, senior member at plaintiffs’ firm Fine Kaplan & Black RPC, asked the court to require that the firms disclose all of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.